IDX-17119
IDX-17119 is a non-nucleoside HCV NS5B RdRp inhibitor with an IC50 of 0.4 nM[1].
Product Specifications
CAS Number
[1987906-92-2]
UNSPSC
12352005
Target
HCV
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(C1=CN(C2=CC=C(C3=NN4C(N)=CC(C)=NC4=C3)C=C2)N=C1NP(OC)(C5=CC=C(C)C=C5C)=O)O
Molecular Formula
C26H26N7O4P
Molecular Weight
531.50
References & Citations
[1]• Manjula Saravanan, et al., The effect of genotype variation and M423 resistance mutations to the binding of phosphonomidate-based inhibitor IDX17119 with the thumb-II domain of Hepatitis C virus RdRp: an integrated molecular dynamics and binding free energy study, 2022 49 (2) :1-11.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
abx228404-01 20 Tests
T-Cell Surface Glycoprotein CD5 (CD5) Antibody (PE / Cyanine 7)
Ask
View Details 
abx228404-02 100 Tests
T-Cell Surface Glycoprotein CD5 (CD5) Antibody (PE / Cyanine 7)
Ask
View Details 
abx228404-03 200 Tests
T-Cell Surface Glycoprotein CD5 (CD5) Antibody (PE / Cyanine 7)
Ask
View Details